You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 2, February 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy
 •Drug Therapy, Other
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Failure of CMV Retinitis With Intravitreal Cidofovir Is Associated With Antiviral Resistance

Irene L. Smith, PhD; Ibrahim Taskintuna, MD; Firas M. Rahhal, MD; Henry C. Powell, MD; Everett Ai, MD; Arthur J. Mueller, MD; Stephen A. Spector, MD; William R. Freeman, MD

Arch Ophthalmol. 1998;116:178-185.

Objectives  To determine the incidence of clinical resistance to intraocular cidofovir injection for treatment of acquired immunodeficiency syndrome (AIDS)-related cytomegalovirus (CMV) retinitis, and to identify virologic features associated with cidofovir treatment failure.

Patients and Methods  Clinical resistance to intravitreal cidofovir was examined in 64 patients with CMV retinitis who received at least 1 injection of 20 µg of cidofovir. Histopathologic examination, culture, and polymerase chain reaction were used to detect CMV in ocular specimens. Antiviral resistance was assessed by plaque reduction assay and DNA sequencing.

Results  Clinical resistance to intravitreal cidofovir injections was identified in 3 patients (5%) and was associated with prior oral ganciclovir or intravenous cidofovir use. Ganciclovir- and cidofovir-resistant CMV isolates were cultured from 2 patients and harbored resistance-associated mutations in the UL97 and polymerase genes. Resistance mutations were also detected by direct analysis of vitreous. In 1 patient, different resistance mutations were identified in ocular vs extraocular CMV strains.

Conclusions  Clinical failure of intravitreal cidofovir occurs infrequently, but may be associated with cidofovir-resistant CMV selected by prior ganciclovir or cidofovir treatment. Ocular CMV disease can result from a localized infection with a resistant CMV strain, and antiviral resistance may develop at a local site of infection independently from resistance that develops systemically.


From the Departments of Pediatrics (Drs Smith and Spector), Ophthalmology (Drs Taskintuna, Rahhal, Mueller, and Freeman), and Pathology (Dr Powell) and the Centers for Molecular Genetics and AIDS Research (Dr Spector), University of California at San Diego, La Jolla; and Pacific Medical Center, San Francisco, Calif (Dr Ai).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Immune Recovery Vitritis Associated With Inactive Cytomegalovirus Retinitis: A New Syndrome
Marietta P. Karavellas, Careen Y. Lowder, J. Christopher Macdonald, Cesar P. Avila, Jr, and William R. Freeman
Arch Ophthalmol. 1998;116(2):169-175.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human Cytomegalovirus Glycoproteins gB and gH/gL Mediate Epithelial Cell-Cell Fusion When Expressed either in cis or in trans
Vanarsdall et al.
J. Virol. 2008;82:11837-11850.
ABSTRACT | FULL TEXT  

Characterization of the Human Cytomegalovirus gH/gL/UL128-131 Complex That Mediates Entry into Epithelial and Endothelial Cells
Ryckman et al.
J. Virol. 2008;82:60-70.
ABSTRACT | FULL TEXT  

Cytomegalovirus blocks intestinal stroma-induced down-regulation of macrophage HIV-1 infection.
Maheshwari et al.
J. Leukoc. Biol. 2006;80:1111-1117.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus Entry into Epithelial and Endothelial Cells Depends on Genes UL128 to UL150 and Occurs by Endocytosis and Low-pH Fusion
Ryckman et al.
J. Virol. 2006;80:710-722.
ABSTRACT | FULL TEXT  

New Reporter Cell Line To Evaluate the Sequential Emergence of Multiple Human Cytomegalovirus Mutations during In Vitro Drug Exposure
Gilbert and Boivin
Antimicrob. Agents Chemother. 2005;49:4860-4866.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus UL131 Open Reading Frame Is Required for Epithelial Cell Tropism
Wang and Shenk
J. Virol. 2005;79:10330-10338.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus Resistance to Antiviral Drugs
Gilbert and Boivin
Antimicrob. Agents Chemother. 2005;49:873-883.
FULL TEXT  

Coding potential of laboratory and clinical strains of human cytomegalovirus
Murphy et al.
Proc. Natl. Acad. Sci. USA 2003;100:14976-14981.
ABSTRACT | FULL TEXT  

Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact
Baldanti and Gerna
J Antimicrob Chemother 2003;52:324-330.
ABSTRACT | FULL TEXT  

The Antiviral Resistance and Replication of Cidofovir-Resistant Adenovirus Variants in the New Zealand White Rabbit Ocular Model
Romanowski et al.
IOVS 2001;42:1812-1815.
ABSTRACT | FULL TEXT  

Resistance of Human Cytomegalovirus to Antiviral Drugs
Erice
Clin. Microbiol. Rev. 1999;12:286-297.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.